Leveraging Redox Dysregulation to Target Latent HIV Infection

Watch a 53-minute research seminar from Johns Hopkins Medicine where Dr. Luca Shytaj presents findings on targeting latent HIV infection through redox dysregulation mechanisms. Explore cutting-edge research that investigates novel therapeutic approaches for addressing HIV latency by manipulating cellular redox states. Gain insights into the relationship between oxidative stress pathways and viral persistence, and learn about potential new strategies for HIV treatment. The presentation delves into complex molecular mechanisms while making the content accessible for medical professionals and researchers interested in HIV therapeutics and neurovirology.